SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Epigral - Quaterly Results

09 Nov 2024 Evaluate
The sales figure stood at Rs. 6260.60 millions for the September 2024 quarter. The mentioned figure indicates a growth of about 30.93% as compared to Rs. 4781.50 millions during the year-ago period.The company almost doubled its revenue to Rs. 805.30 millions  from Rs. 381.30 millions in the quarter ended September 2024.OP of the company witnessed a marginal growth to 1839.80 millions from 1088.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 6260.60 4781.50 30.93 12772.60 9330.40 36.89 19291.92 21884.00 -11.84
Other Income 55.50 10.00 455.00 79.50 25.20 215.48 65.15 79.84 -18.40
PBIDT 1839.80 1088.60 69.01 3627.80 2055.70 76.48 4877.26 6969.81 -30.02
Interest 273.20 212.70 28.44 415.70 396.00 4.97 734.89 655.02 12.19
PBDT 1566.60 875.90 78.86 3212.10 1659.70 93.53 4142.37 6314.79 -34.40
Depreciation 322.50 315.10 2.35 657.00 623.10 5.44 1235.64 1089.53 13.41
PBT 1244.10 560.80 121.84 2555.10 1036.60 146.49 2906.73 5225.26 -44.37
TAX 438.80 179.50 144.46 889.70 338.50 162.84 948.84 1691.69 -43.91
Deferred Tax 219.60 76.10 188.57 438.80 146.60 199.32 421.74 748.61 -43.66
PAT 805.30 381.30 111.20 1665.40 698.10 138.56 1957.89 3533.57 -44.59
Equity 415.50 415.50 0.00 415.50 415.50 0.00 415.50 415.50 0.00
PBIDTM(%) 29.39 22.77 29.08 28.40 22.03 28.92 25.28 31.85 -20.62

Epigral Share Price

1187.20 17.90 (1.53%)
22-Apr-2026 13:09 View Price Chart
Peers
Company Name CMP
BASF India 3741.70
Tata Chemicals 709.50
SRF 2500.95
Pidilite Inds. 1411.30
Deepak Nitrite 1721.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×